Table 2. Clinicopathologic features of neuroendocrine carcinoma of esophagus.
| Case | CEA | SCC | NSE | Pro-GRP | Treatment | Period (Months) | Status |
|---|---|---|---|---|---|---|---|
| 1 | 1.4 | 0.4 | Surg | >70 | alive | ||
| 2 | 1.5 | 0.6 | 6.4 (<10) | 29.5 (<46) | |||
| 3 | 5.3 | 0.4 | 15.7 (<16.3) | Surg | 7 | died | |
| 4 | 1.1 | 0.7 | 12.8 (<16.3) | 267 (<46) | Surg, CTx | 12 | alive |
| 5 | 4.6 | 0.4 | CTx | 17 | died | ||
| 6 | 2.6 | 0.8 | 11 (<10) | 171 (<46) | CTx, RTx | 10 | died |
| 7 | 1.6 | 0 | 8.6 (<10) | 18.3 (<70) | CTx, RTx | 17 | died |
| 8 | 1.2 | 2.3 | CRTx | 8 | died | ||
| 9 | 5.9 | 1.4 | CTx | ||||
| 10 | 19.6 | 1.1 | 130 (<10) | 1670 (<46) | CTx | 9 | died |
| 11 | 7.8 | 0.8 | 28 (<10) | CTx, RTx | 13 | died | |
| 12 | 2.4 | 0.7 | CTx | 14 | died | ||
| 13 | 2.3 | 1.6 | 12.8 (<16.3) | 25.8 (<46) | CTx, RTx | 6 | died |
| 14 | 13.9 | 1 | 17.4 (<16.3) | CTx | 4 | died |
Surg; Surgery, CTx; Chemotherapy, RTx; Radiotherapy, CRTx; Chemoradiotherapy